Disposable electrochemical detection of breast cancer tumour marker CA 15-3 using poly(Toluidine Blue) as imprinted polymer receptor

被引:92
|
作者
Ribeiro, J. A. [1 ,2 ]
Pereira, C. M. [1 ]
Silva, A. F. [1 ]
Sales, M. Goreti F. [2 ]
机构
[1] Univ Porto, Fac Sci, Dept Chem & Biochem, CIQUP, Porto, Portugal
[2] Polytech Inst Porto, Sch Engn, BioMark CINTESIS ISEP, Porto, Portugal
来源
基金
欧洲研究理事会;
关键词
Biosensor; Carbohydrate antigen 15-3; Toluidine Blue; Screen-printed gold electrode; Molecularly-imprinted polymer; HORSERADISH-PEROXIDASE; SIGNAL AMPLIFICATION; MODIFIED ELECTRODE; HYDROGEN-PEROXIDE; AMPEROMETRIC BIOSENSORS; CARDIAC BIOMARKER; ANTIGEN CA15-3; IMMUNOSENSOR; GRAPHENE; SURFACE;
D O I
10.1016/j.bios.2018.03.011
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
In this work, electrically-conducting poly(Toludine Blue) was employed for the first time as synthetic receptor film, prepared by Molecular Imprinting strategies and using electrochemical methods, for the specific screening of breast cancer biomarker Carbohydrate Antigen 15.3 (CA 15-3). The protein imprinted poly(Toluidine Blue) film was grown in a pre-formed Toluidine Blue (TB) tailed SAM at the AuSPE surface, which greatly enhanced the stability against degradation of the Molecular Imprinted Polymer (MIP) film at the electrode surface. The MIP receptor film recognition ability towards the protein was investigated by fitting data to Freundlich isotherm. The binding affinity (K-p) obtained for the MIP system was significantly higher (similar to 12-fold) to that obtained for the NIP system, demonstrating the success of the approach in creating imprinted materials that specifically respond to CA 15-3 protein. The incubation of the MIP modified electrode with increasing concentration of protein (from 0.10 U mL(-1) to 1000 U mL(-1)) resulted in a decrease of the ferro/ferricyanide redox current. The device displayed linear response from 0.10 U mL(-1) to 100 U mL(-1) and LODs below 0.10 U mL(-1) were obtained from calibration curves built in neutral buffer and diluted artificial serum, using DPV technique, enabling the detection of the protein biomarker at clinically relevant levels. The developed MIP biosensor was applied to the determination of CA 15-3 in spiked serum samples with satisfactory results. The developed device provides a new strategy for sensitive, rapid, simple and cost-effective screening of CA 15-3 biomarker. Importantly, the overall approach seems suitable for point-of-care (PoC) use in clinical context.
引用
收藏
页码:246 / 254
页数:9
相关论文
共 50 条
  • [1] Electrochemical immunosensor to detect breast cancer marker CA 15-3 antibody
    Patil, S. M.
    Karade, V. C.
    Kim, J. H.
    Chougale, A. D.
    Patil, P. B.
    MATERIALS TODAY COMMUNICATIONS, 2022, 33
  • [2] Disposable electropolymerized molecularly imprinted electrochemical sensor for determination of breast cancer biomarker CA 15-3 in human serum samples
    Oliveira, Ana Elisa F.
    Pereira, Arnaldo C.
    Ferreira, Lucas F.
    TALANTA, 2023, 252
  • [3] Tumour marker CA 15-3 in the follow-up of breast cancer progression
    Prtenjak, G
    Kerenji, A
    JUGOSLOVENSKA MEDICINSKA BIOHEMIJA-YUGOSLAV MEDICAL BIOCHEMISTRY, 1998, 17 (03): : 174 - 174
  • [4] CA 15-3: a prognostic marker in breast cancer
    Duffy, MJ
    Shering, S
    Sherry, F
    McDermott, E
    O'Higgins, N
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2000, 15 (04): : 330 - 333
  • [5] Molecularly imprinted electrochemical sensor for the point-of-care detection of a breast cancer biomarker (CA 15-3)
    Pacheco, Joao G.
    Silva, Marta S. V.
    Freitas, Maria
    Nouws, Henri P. A.
    Delerue-Matos, Cristina
    SENSORS AND ACTUATORS B-CHEMICAL, 2018, 256 : 905 - 912
  • [6] Clinical utility of tumour marker velocity of cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA) in breast cancer surveillance
    Hing, J. X.
    Mok, C. W.
    Tan, P. T.
    Sudhakar, S. S.
    Seah, C. M.
    Lee, W. P.
    Tan, S. M.
    BREAST, 2020, 52 : 95 - 101
  • [7] CA 15-3, ceruloplasmin and tissue polypeptide specific antigen as a tumour marker panel in breast cancer
    Özyilkan, Ö
    Baltali, E
    Kirazli, S
    EAST AFRICAN MEDICAL JOURNAL, 2000, 77 (06) : 291 - 294
  • [8] STUDIES ON CA 15-3, A NEW MARKER IN BREAST-CANCER
    DUFFY, MJ
    SHERRY, F
    CLINICAL SCIENCE, 1986, 71 : P28 - P28
  • [9] Evaluation of the benefit of the tumor marker cancer antigen 15-3 (CA 15-3) in different subtypes of metastatic breast cancer
    Lindman, Henrik
    Molin, Ebba Cederqvist
    Jernling, Martin
    Schiza, Aglia
    CANCER RESEARCH, 2023, 83 (05)
  • [10] CA 15-3 tumor marker for breast cancer screening and prevention.
    Muradyan, A
    Avagyan, H
    Doumanyan, D
    Amiryan, S
    Karabashyan, L
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1160S - 1160S